Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
Weill Medical College of Cornell University
Weill Medical College of Cornell University
Massachusetts General Hospital
Boston University
Assistance Publique - Hôpitaux de Paris
University of Washington
Roswell Park Cancer Institute
University of Washington
Memorial Sloan Kettering Cancer Center
University of California, Davis
Columbia University
Dana-Farber Cancer Institute
Fondazione Italiana Linfomi - ETS
Academic and Community Cancer Research United
Columbia University
AHS Cancer Control Alberta
University of California, San Francisco
University of Chicago
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
Stanford University
University of Nebraska
University of Nebraska
Washington University School of Medicine
Augusta University
University of Washington
Swiss Cancer Institute
Fred Hutchinson Cancer Center
Medical College of Wisconsin
Swiss Cancer Institute
The First Affiliated Hospital with Nanjing Medical University
University of Southampton
Rush University Medical Center
Weill Medical College of Cornell University
Northwestern University
Columbia University
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Mercy Health Ohio
University Hospital, Brest
Baylor College of Medicine
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center
Northwestern University